TERT and neoplasm: Examining the possible interaction between TERT promoter mutations and BRAFV600E, the mortality rate for subjects whose tumours were wild type for both genotypes was 0/18; for TERT‐mutated but wild‐type BRAF 0/3; for BRAFV600E but wild‐type TERT 1/51 (2%); and for TERT mutated and BRAFV600E together mortality was 3/8 (38%).